Literature DB >> 10561820

The 'ABC' of GABA receptors: a brief review.

M Chebib1, G A Johnston.   

Abstract

1. In the mammalian central nervous system, GABA is the main inhibitory neurotransmitter. GABA is a highly flexible molecule and, thus, can exist in many low-energy conformations. Conformationally restricted analogues of GABA have been used to help identify three major GABA receptors, termed GABAA, GABAB and GABAC receptors. 2. GABAA and GABAC receptors are members of a super-family of transmitter-gated ion channels that include nicotinic acetylcholine, strychnine-sensitive glycine and 5HT3 receptors. GABAA receptors are hetero-oligomeric Cl- channels that are selectively blocked by the alkaloid bicuculline and modulated by steroids, barbiturates and benzodiazepines. To date, 16 human GABAA receptor cDNA have been cloned. 3. GABAB receptors are seven transmembrane receptors that are coupled to G-proteins and activate second messenger systems and Ca2+ and K+ ion channels. To date, three GABAB receptor proteins have been cloned and these resemble metabotropic glutamate receptors. GABAB receptors are hetero-oligomeric receptors made up of a mixture of a combination of the subunits. These receptors are selectively activated by (-)-baclofen and CCGP27492 and are blocked by phaclofen, the phosphonic acid analogue of baclofen. 4. In contrast, GABAC receptors represent a relatively simple form of transmitter-gated Cl- channel made up of a single type of protein subunit. Two human GABAC receptor cDNA have been cloned. These receptors are not blocked by bicuculline nor are they modulated by steroids, barbiturates or benzodiazepines. Instead, GABAC receptors are selectively activated by the conformationally restricted analogues of GABA in the folded conformation cis-4-aminocrotonic acid and (1s,2R)-2-(aminomethyl)-1-carboxycyclopropane. (1,2,5,6-Tetrahydropyridine-4-yl)methylphosphinic acid, a methylphosphinic acid analogue of GABA in a partially folded conformation, is a selective antagonist at GABAC receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561820     DOI: 10.1046/j.1440-1681.1999.03151.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  73 in total

Review 1.  Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety.

Authors:  Xia Chen; Joop van Gerven; Adam Cohen; Gabriel Jacobs
Journal:  Acta Pharmacol Sin       Date:  2018-12-05       Impact factor: 6.150

Review 2.  CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Authors:  Karl-Erik Andersson; Rikard Pehrson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  GABAB receptor activation inhibits exocytosis in rat pancreatic beta-cells by G-protein-dependent activation of calcineurin.

Authors:  Matthias Braun; Anna Wendt; Karsten Buschard; Albert Salehi; Sabine Sewing; Jesper Gromada; Patrik Rorsman
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182

4.  GABA receptors ameliorate Hcy-mediated integrin shedding and constrictive collagen remodeling in microvascular endothelial cells.

Authors:  Suresh Shastry; Neetu Tyagi; Karni S Moshal; David Lominadze; Melvin R Hayden; Suresh C Tyagi
Journal:  Cell Biochem Biophys       Date:  2006       Impact factor: 2.194

5.  GAD1 Upregulation Programs Aggressive Features of Cancer Cell Metabolism in the Brain Metastatic Microenvironment.

Authors:  Patricia M Schnepp; Dennis D Lee; Ian H Guldner; Treasa K O'Tighearnaigh; Erin N Howe; Bhavana Palakurthi; Kaitlyn E Eckert; Tiffany A Toni; Brandon L Ashfeld; Siyuan Zhang
Journal:  Cancer Res       Date:  2017-04-11       Impact factor: 12.701

6.  Graham Johnston: bringing success to neuroscience through medicinal chemistry. Preface.

Authors:  Philip M Beart; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2009-05-30       Impact factor: 3.996

7.  GABAC receptor-mediated inhibition is altered but not eliminated in the superior colliculus of GABAC rho1 knockout mice.

Authors:  Katja Schlicker; Maureen A McCall; Matthias Schmidt
Journal:  J Neurophysiol       Date:  2009-03-25       Impact factor: 2.714

Review 8.  Neurotransmitter signaling in postnatal neurogenesis: The first leg.

Authors:  Jean-Claude Platel; Séverine Stamboulian; Ivy Nguyen; Angélique Bordey
Journal:  Brain Res Rev       Date:  2010-02-24

9.  Chloride sensing by WNK1 involves inhibition of autophosphorylation.

Authors:  Alexander T Piala; Thomas M Moon; Radha Akella; Haixia He; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

10.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.